Cardiol Therapeutics Inc. (CRDL)

Price & Market Data

Price: $1.32

Daily Change: +$0.01 / 0.76%

Daily Range: $1.32 - $1.38

Market Cap: $152,159,360

Daily Volume: 275,972

Performance Metrics

1 Week: 1.87%

1 Month: -16.26%

3 Months: 31.25%

6 Months: 39.29%

1 Year: 28.77%

YTD: 42.19%

About Cardiol Therapeutics Inc. (CRDL)

Data on Cardiol Therapeutics Inc. (CRDL). Price: 1.32, daily change: +$0.01 / 0.76%. Market cap: 152,159,360. Performance YTD and 1-year.

Company Details

Employees: 23

Sector: Health technology

Industry: Biotechnology

Country: Canada

Details

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38, a novel subcutaneously administered drug formulation of cannabidiol for the treatment of heart failure. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

Selected stocks

Lloyds Banking Group Plc (LYG)

Masonglory Limited (MSGY)

GoPro, Inc. (GPRO)

Ming Shing Group Holdings Limited (MSW)

FS Credit Opportunities Corp. (FSCO)